4DMedical Limited
Tracked across 2 events · 14 articles · First seen Apr 20, 2026 · Last active Jun 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: 4DMedical Limited received TGA approval for its CT:VQ technology, enabling commercial deployment across Australia, which is a significant market for the company due to its high CT scanner density. This expands the company's market reach and potential revenue.
Jun 29, 2026 · 8 articles
Business
Impact: 4DMedical Limited was one of the presenting companies at the Life Sciences Virtual Investor Forum.
Jun 26, 2026 · 6 articles
100
Australia — Therapeutic Goods Administration granted approval 4DMedical Limited4DMedical CT:VQ TGA...
ERGEN INTELLIGENCE
Track 4DMedical Limited live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard